Fair Value Calculator Fair Value Calculator
EN DE

ORCHASP (ORCHASP) Fair Value & Analysis

IN · Market cap ₹665M

O ORCHASP ORCHASP · BSE
Price₹1.92
Fair Value₹0.5200
Upside-72.9%
Quality28/100
Watch ORCHASP for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹0.3900 – ₹0.6500

Fair value as of: Jul 5, 2026

From 10 valuation models · updated today

Share price −2.5% over the past month.

Price vs Fair Value (12 months)

₹4.01 ₹1.76 Fair Value ₹0.5200 Jul 2025 Jul 2026

12‑month range ₹1.76 – ₹4.01 · fair‑value band ₹0.3900 – ₹0.6500 · the ₹1.92 price screens above the ₹0.5200 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ORCHASP (ORCHASP) currently trades at ₹1.92, while our model-based Fair Value estimate is ₹0.5200 — implying the stock looks roughly 72.9% overvalued today. We read business quality at 28/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, ORCHASP generated revenue of ₹213M at a net margin of 5.0%. Revenue declined 77.0% year over year. It earns a return on equity of 0.9%. Net debt stands at ₹153M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹0.3900 (bear case) to ₹0.6500 (bull case); at ₹1.92, the current price sits above that range. The share trades about 54% below its 52-week high and 23% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹213M
Revenue growth (YoY) -77.0%
Net margin 5.0%
Return on equity 0.9%
Free cash flow −₹42.2M FY2026
P/E ratio 64.0
More key figures
Operating margin -253%
EPS (TTM) ₹0.0300
EPS growth (YoY) -71.9%
Net debt ₹153M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ORCHASP reported revenue of ₹213M in FY2026 versus ₹373M in FY2022, a compound −13.1%/yr. Reported net income was ₹10.5M in FY2026, compounding +108.3%/yr from FY2022.

Revenue −13.1%/yr
FY22 ₹373M
FY23 ₹235M
FY24 ₹132M
FY25 ₹211M
FY26 ₹213M
Net income +108.3%/yr
FY22 ₹559K
FY23 ₹3.5M
FY24 ₹6.8M
FY25 −₹105M
FY26 ₹10.5M

Is ORCHASP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "ORCHASP Fair Value". https://www.fairvalue-calculator.com/stock/ORCHASP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ORCHASP (ORCHASP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹0.5200 versus a price of ₹1.92 — about −73% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ORCHASP?
Our model-based fair value for ORCHASP is ₹0.5200 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹1.92.
What is the quality score of ORCHASP?
ORCHASP has a Quality Score of 28/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ORCHASP (ORCHASP)?
ORCHASP reported trailing-twelve-month revenue of about ₹213M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of ORCHASP?
The net profit margin of ORCHASP is about 5.0%, meaning it keeps roughly 5.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.